BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zornitzki T, Malnick S, Lysyy L, Knobler H. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World J Gastroenterol 2015; 21(1): 233-239 [PMID: 25574096 DOI: 10.3748/wjg.v21.i1.233]
URL: https://www.wjgnet.com/1948-5182/full/v21/i1/233.htm
Number Citing Articles
1
Anne Op de Beeck, Decio L. Eizirik. Viral infections in type 1 diabetes mellitus — why the β cells?Nature Reviews Endocrinology 2016; 12(5): 263 doi: 10.1038/nrendo.2016.30
2
James Yue Zhang, Curtis Cooper, Mary-Anne Doyle. Association between hepatitis C antiviral treatment and diabetes mellitus: A case seriesOfficial Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(2): 104 doi: 10.3138/jammi-2019-0007
3
Linghuan Wang, Kang Chen, Meirong Wang, Zhaohui Lv, Weijun Gu, Xianling Wang, Qi Ni, Yiming Mu. Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A ReviewHormone and Metabolic Research 2022; 54(03): 145 doi: 10.1055/a-1749-5716
4
G. Liamis, T. D. Filippatos, A. Liontos, M. S. Elisaf. Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromiseHepatology International 2016; 10(5): 762 doi: 10.1007/s12072-016-9746-1
5
Virginie S.E. Jean-Baptiste, Chang-Qing Xia, Michael J. Clare-Salzler, Marc S. Horwitz. Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the PancreasEBioMedicine 2017; 22: 10 doi: 10.1016/j.ebiom.2017.06.014
6
Mochuan Chen, Bing Zhu, Dong Chen, Xingzhong Hu, Xueqin Xu, Wen-Jun Shen, Chenchan Hu, Jue Li, Shen Qu. COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective StudyEndocrine Practice 2021; 27(8): 834 doi: 10.1016/j.eprac.2021.04.004
7
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationshipWorld Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
8
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
9
Izabella Jasyk, Jakub Siednienko. Type I interferon therapies of multiple sclerosis and hepatitis C virus infectionPostępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 537 doi: 10.2478/ahem-2021-0001
10
Laura Marroqui, Atenea Alexandra Perez-Serna, Ignacio Babiloni-Chust, Reinaldo Sousa Dos Santos. Pancreatic ß-Cell Biology in Health and DiseaseInternational Review of Cell and Molecular Biology 2021; 359: 1 doi: 10.1016/bs.ircmb.2021.02.011
11
Irena Pintea, Carina Petricau, Dinu Dumitrascu, Adriana Muntean, Daniel Branisteanu, Daciana Branisteanu, Diana Deleanu. Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review)Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10381
12
W. Ma, X. Yuan, X. Wu, Y. Li, X. Xiao, H. Zhang, F. Ping, H. Yang. A rare form of diabetes and a rare complication of treatmentDiabetic Medicine 2020; 37(11): 1954 doi: 10.1111/dme.14357
13
Shakila Sabir, Muhammad Furqan Akhtar, Ammara Saleem. Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticalsEnvironmental Science and Pollution Research 2019; 26(2): 1277 doi: 10.1007/s11356-018-3774-4
14
Manu Pandey, Itivrita Goyal, Marc S. Ernstoff. Handbook of Cancer Treatment-Related Symptons and Toxicities2020; : 187 doi: 10.1016/B978-0-323-67241-2.00018-5
15
Vandana Jain, Ronak Kumar Patel, Zaureen Kapadia, Sneha Galiveeti, Maryann Banerji, Lisel Hope. Drugs and hyperglycemia: A practical guideMaturitas 2017; 104: 80 doi: 10.1016/j.maturitas.2017.08.006
16
Sho Yoneda, Akihisa Imagawa, Kenji Fukui, Sae Uno, Junji Kozawa, Makoto Sakai, Toshiki Yumioka, Hiromi Iwahashi, Iichiro Shimomura. A Histological Study of Fulminant Type 1 Diabetes Mellitus Related to Human Cytomegalovirus ReactivationThe Journal of Clinical Endocrinology & Metabolism 2017; 102(7): 2394 doi: 10.1210/jc.2016-4029
17
Benedetta Terziroli Beretta-Piccoli, Claudia Di Bartolomeo, Gaia Deleonardi, Ana Gabriela Grondona, Tania Silvestri, Cinzia Tesei, Laura Melidona, Andreas Cerny, Joachim Mertens, Nasser Semmo, David Semela, Darius Moradpour, Giorgina Mieli-Vergani, Diego Vergani, Luigi Muratori. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agentsJournal of Autoimmunity 2019; 102: 89 doi: 10.1016/j.jaut.2019.04.019
18
Matthew B. Johnson, Karen Cerosaletti, Sarah E. Flanagan, Jane H. Buckner. Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune DiabetesCurrent Diabetes Reports 2019; 19(5) doi: 10.1007/s11892-019-1141-6
19
M Battaglia, J H Buckner, M K Levings, S J Richardson, F S Wong, T I Tree. Identifying the ‘Achilles heel’ of type 1 diabetesClinical and Experimental Immunology 2021; 204(2): 167 doi: 10.1111/cei.13570
20
Tomasz Wandtke, Joanna Woźniak, Piotr Kopiński. Aptamers in Diagnostics and Treatment of Viral InfectionsViruses 2015; 7(2): 751 doi: 10.3390/v7020751
21
Cheng-Hung Chien, Chih-Lang Lin, Ching-Chih Hu, Jia-Jang Chang, Rong-Nan Chien. Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin TherapyJournal of Interferon & Cytokine Research 2015; 35(12): 981 doi: 10.1089/jir.2014.0200
22
Chia-Yen Dai. Insulin resistance and anti-hepatitis C virus therapyAdvances in Digestive Medicine 2016; 3(2): 37 doi: 10.1016/j.aidm.2016.03.004
23
Gautam Das, Hemanth Bolusani. Hepatitis C virus infection and diabetesPractical Diabetes 2016; 33(4): 123 doi: 10.1002/pdi.2017
24
Howard Chung, Peter HR Green, Timothy C Wang, Xiao-Fei Kong. Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the EvidenceJournal of Inflammation Research 2021; : 5187 doi: 10.2147/JIR.S280953
25
Xiao-Guang Dou, Han Bai. Diagnosis and treatment of chronic hepatitis C with concomitant extrahepatic manifestations deserves a closer lookJournal of Translational Internal Medicine 2017; 5(1): 1 doi: 10.1515/jtim-2017-0009
26
Barbara M. Schulte, Paul R. Gielen, Esther D. Kers-Rebel, Amy C. Prosser, Katharina Lind, Malin Flodström-Tullberg, Cees J. Tack, Lammy D. Elving, Gosse J. Adema. Enterovirus Exposure Uniquely Discriminates Type 1 Diabetes Patients with a Homozygous from a Heterozygous Melanoma Differentiation-Associated Protein 5/Interferon Induced with Helicase C Domain 1 A946T GenotypeViral Immunology 2016; 29(7): 389 doi: 10.1089/vim.2015.0140
27
Endrit Shahini, Andrea Iannone, Domenico Romagno, Angelo Armandi, Sonia Carparelli, Mariabeatrice Principi, Maria Teresa Viggiani, Enzo Ierardi, Alfredo Di Leo, Michele Barone. Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapyAlimentary Pharmacology & Therapeutics 2018; 48(10): 1138 doi: 10.1111/apt.14999
28
Zeinab A. Elkabbany, Nancy S. Elbarbary, Eman A. Ismail, Nesrine A. Mohamed, Dina Ragab, Shereen Abdel Alem, Yasmine M. Ezzat, Sarah S. Maurice, Noha U. Hashem. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitusJournal of Diabetes and its Complications 2017; 31(1): 186 doi: 10.1016/j.jdiacomp.2016.09.009
29
S. John Calise, Edward K.L. Chan. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discoveryAutoimmunity Reviews 2020; 19(10): 102643 doi: 10.1016/j.autrev.2020.102643